AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
AstraZeneca reported on Monday that its experimental weight-loss pill, AZD5004, licensed from China's Eccogene for up to $2 billion, was found safe and tolerable in an early-stage trial.
The study, which included 72 participants who were either healthy or had type 2 diabetes, showed side effects consistent with other GLP-1 drugs, such as nausea and vomiting. Based on these findings, AstraZeneca has advanced AZD5004 to Phase II trials focused on weight reduction in overweight and obese individuals, with completion expected by late 2025.
Unlike injectable treatments from competitors Eli Lilly and Novo Nordisk, AZD5004 is a small molecule pill that can be combined with other medications and taken with or without food, offering potential advantages for patients with additional health conditions.
AstraZeneca also shared early-stage data on other obesity drugs, AZD6234 and AZD9550, which target different hunger-related hormones and will undergo further Phase II testing through 2026.
Meanwhile, Viking Therapeutics released early trial results for its own oral obesity drug, which briefly boosted its stock before a decline.
Read next
06:05
Canada’s Liberal Party is set to elect a new leader on March 9, moving beyond Justin Trudeau’s decade in power. The race comes as U.S. President Donald Trump’s threats against Canada fuel a wave of patriotism ahead of an expected election.
03:58
French President Emmanuel Macron dismissed Russia’s criticism on Thursday, after the Kremlin warned him over nuclear rhetoric. Speaking at an EU summit in Brussels, he accused Moscow of imperialism and said Russia’s strong reaction showed his claims were true.
03:20
Torrential rains triggered severe flooding in eastern Spain on Thursday, sweeping away cars and forcing school evacuations. Authorities closed roads in Murcia, Valencia, and Catalonia, with officials urging residents to stay indoors.
02:55
Ukrainian President Volodymyr Zelenskyy announced he will visit Saudi Arabia on Monday to meet Crown Prince Mohammed bin Salman, aiming to advance peace efforts. His team will remain in the country for talks with U.S. partners, he said in a Telegram post.
02:10
North Korea criticised upcoming U.S.-South Korea military drills on Friday, warning they would worsen tensions on the Korean Peninsula, state media KCNA reported. The annual Freedom Shield exercises are set to begin on Monday and last until March 20.
What is your opinion on this topic?
Leave the first comment